Falls and resulting fractures in Myotonic Dystrophy: Results from a multinational retrospective survey by Jimenez-Moreno AC et al.
 
 
 
 
 
Newcastle University ePrints | eprint.ncl.ac.uk 
Jimenez-Moreno AC, Raaphorst J, Babacic H, Wood L, van Engelen B, 
Lochmuller H, Schoser B, Wenninger S. Falls and resulting fractures in Myotonic 
Dystrophy: Results from a multinational retrospective survey. Neuromuscular 
Disorders (2018)
DOI link 
https://doi.org/10.1016/j.nmd.2017.12.010  
ePrints link 
http://eprint.ncl.ac.uk/pub_details2.aspx?pub_id=245517  
Date deposited 
29/01/2018 
Embargo release date 
27/12/2018  
Copyright 
© 2018. This manuscript version is made available under the CC-BY-NC-ND 4.0 license 
 
Licence 
This work is licensed under a  
Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International licence 
 
 
Accepted Manuscript 
 
 
Title: Falls and resulting fractures in myotonic dystrophy: results from a 
multinational retrospective survey. 
 
Author: Aura Cecilia Jimenez-Moreno, Joost Raaphorst, Haris Babačić, Libby 
Wood, Baziel van Engelen, Hanns Lochmüller, Benedikt Schoser, Stephan 
Wenninger 
 
PII:  S0960-8966(17)31403-7 
DOI:  https://doi.org/10.1016/j.nmd.2017.12.010 
Reference: NMD 3497 
 
To appear in: Neuromuscular Disorders 
 
Received date: 24-10-2017 
Accepted date: 20-12-2017 
 
 
Please cite this article as:  Aura Cecilia Jimenez-Moreno, Joost Raaphorst, Haris Babačić, Libby 
Wood, Baziel van Engelen, Hanns Lochmüller, Benedikt Schoser, Stephan Wenninger, Falls and 
resulting fractures in myotonic dystrophy: results from a multinational retrospective survey., 
Neuromuscular Disorders (2017), https://doi.org/10.1016/j.nmd.2017.12.010. 
 
This is a PDF file of an unedited manuscript that has been accepted for publication.  As a service 
to our customers we are providing this early version of the manuscript.  The manuscript will 
undergo copyediting, typesetting, and review of the resulting proof before it is published in its 
final form.  Please note that during the production process errors may be discovered which could 
affect the content, and all legal disclaimers that apply to the journal pertain. 
 
 
1 
 
TITLE: Falls and resulting fractures in Myotonic Dystrophy: results from a multinational retrospective 5 
survey. 
 
RUNNING TITLE: Falls and fractures in DM1. 
 
AUTHORS: 10 
Jimenez-Moreno A.C.1, Raaphorst J.2, Babačić H.3, Wood L.1, van Engelen B.2, Lochmüller H.1, Schoser B.3, 
Wenninger S3. 
 
FULL NAMES: 
Aura Cecilia Jimenez-Moreno (Dr, PT) A.C.Jimenez-Moreno@newcastle.ac.uk 15 
Joost Raaphorst (Dr, MD) Joost.Raaphorst@radboudumc.nl 
Haris Babačić (MD) Haris.Babacic@gmail.com 
Libby Wood (Ms) Libby.Wood@newcastle.ac.uk 
Baziel van Engelen (Prof, MD) Baziel.vanEngelen@radboudumc.nl 
Hanns Lochmüller (Prof, MD) Hanns.Lochmuller@newcastle.ac.uk 20 
Benedikt Schoser (Prof, MD) Benedikt.Schoser@med.uni-muenchen.de 
Stephan Wenninger (Dr, MD) Stephan.Wenninger@med.uni-muenchen.de 
 
 
AFFILIATIONS: 25 
1 Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, UK. 
2 Department of Neurology, Radboud University Medical Centre, Nijmegen, The Netherlands. 
3 Department of Neurology, Ludwig-Maximilians-University of Munich, Munich, Germany. 
Stephan.Wenninger@med.uni-muenchen.de 
A.C.Jimenez-Moreno@newcastle.ac.uk 30 
 
 
FULL CONTACT DETAILS: 
Dr. Stephan Wenninger MD. 
Stephan.Wenninger@med.uni-muenchen.de 35 
Friedrich-Baur-Institut 
Department of Neurology 
Ziemssenstr. 1a 
80336 München 
Germany 40 
P: +49(0)894400-57470  
 
 
Title character count: 76 
Abstract word count: 295 45 
Manuscript overall word count (references section excluded): 3,553 
 
 
KEY WORDS: myotonic dystrophy; DM1; falls; fractures; balance 
  50 
Page 1 of 18
2 
 
Highlights 5 
This is the first high scale survey for falls and fractures for Myotonic Dystrophy 1 
DM1 adults showed 2.3 more risk of falling than a healthy over 65 years of age 
These results presented no impact of respondent sex for risk of falls 
Age showed to be a significant predictor for falls in DM1 
Falls in DM1 is still an unpredicted & underestimated factor that requires attention 10 
 
 
ABSTRACT 
 
Myotonic Dystrophy type 1 multisystem involvement leads to functional impairment with an increased 15 
risk of falling. This multinational study estimates the prevalence of falls and fall-associated fractures. A 
web-based survey among disease-specific registries (Germany, UK and the Netherlands) was carried out 
among DM1 ambulant adults with a total of 573 responses retrieved. Results provided a risk ratio 
estimation of 30-72% for falls and of 11-17% for associated fractures. There was no significant difference 
for falls between male and female, but there was for fall-related fractures with a higher prevalence in 20 
women. Balance and leg weakness were the most commonly reported causes for falling. This study is 
based on a voluntary retrospective survey with naturally inherent limitations; however, the sample size 
allows for robust comparisons. The estimated risk of falls in this cohort with a mean age of 46 years 
compares to a previous estimation for a healthy population of over 65 years of age. These results suggest 
a premature-ageing DM1 phenotype with an increased risk of falling depending on age and disease 25 
severity that, so far, might have been underestimated. This may have clinical implications for the 
development of care guidelines and when testing new interventions in this population.   
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INTRODUCTION 5 
 
Myotonic Dystrophy type 1 (DM1) is an autosomal dominant neuromuscular disorder that affects 
approximately 1 in 8,000 people, being the most common of this disease group in adults (1). This disease 
phenotype is predominantly defined by a genotype of an unstable and variable CTG-triplet expansion that 
causes mRNA mis-splicing in various cellular processes affecting different tissues and organs (2). Myotonic 10 
dystrophy is a progeroid multisystemic disease that affects primarily the muscles and nervous system 
with impaired function (3, 4). 
 
Falls and stumbles have been a matter of concern among the Myotonic Dystrophy research community 
since Wiles et al. (5) reported a tenfold increased prevalence when compared to healthy controls. These 15 
have been objectively associated with still-ambulant patients with muscle weakness and impaired balance 
(6, 7), yet there are other characteristics that accompany this population’s phenotype that should also be 
considered as risk factors for falls: gait and mobility disturbances; visual impairment; inactivity; socio-
economic status; intake of cardiac medications; and cognitive impairment (8-11). In addition, due to the 
low levels of vitamin D3 present in some DM1 patients, particularly males with androgen insufficiency, 20 
there is the hypothesis of a higher incidence of fractures that requires further investigation (12). 
 
However, it is thought that falls are under-reported in this population, which might be reflected by an 
inaccurate estimation of prevalence (13). Additionally, falls should be considered when developing 
protocols for clinical trials and therapeutic interventions. Patient registries allow for access to large 25 
populations of engaged patients, and allow for the easy distribution of questionnaires through web-based 
surveys. This enables the collection of patient-reported data from large cohorts that would otherwise not 
be possible in rare diseases such as DM1. This type of recollection has been shown to provide informative 
data applicable to a range of outcomes or hazards (14). This research has aimed to capture the recent 
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overall incidence and prevalence of falls and fall-related fractures in DM1 across three countries (United 5 
Kingdom, Germany and the Netherlands). It is expected that this report will increase awareness of falls 
and fall-risk factors both for healthcare providers and clinical research teams.  
 
METHODS 
 10 
Survey design and procedure 
The data set for this report was obtained from a web-based retrospective survey undertaken between 
August 2016 and January 2017. Three European centres from different countries (a. The Friedrich-Baur-
Institut, Munich, Germany; b. The John Walton Muscular Dystrophy Research Centre, Newcastle-upon-
Tyne, UK; c. The Radboud University Medical Centre, Nijmegen, the Netherlands), all representing highly 15 
specialized neuromuscular research centres, participated in this process. Experts from the participating 
centresa, taking into account the sites’ differences to ensure understanding and to reduce the risk of 
recall bias, initially designed the survey in English. This was then translated into German and Dutch. The 
survey was distributed online to DM1 patients in accordance with the protocols of the relevant patient 
registries and databases (The UK Myotonic Dystrophy Patient Registry, UK (15); the Dutch neuromuscular 20 
database, CRAMP, the Netherlands (16); and the patient registry for myotonic dystrophies in Germany, 
MD-Net, Germany). Each centre went through local ethical and steering committee approvals concerning 
each registry’s policies and through what were considered appropriate cultural adaptationsc. Any 
resulting differences were considered before analysis to avoid any inappropriate conclusions (e.g. the 
German version collected falls recall from the last 12 months and the Dutch and the English versions from 25 
the last 6 months, hence prevalence estimations were not pulled out as a group). The English version of 
this questionnaire can be provided as an additional document. This report is limited to the data obtained 
via this survey so avoiding additional variabilities between registries.  
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Sample 5 
Invited participants represent genetically confirmed DM1 adults who are registered on the DM registry or 
database in their country. Only DM1 patients who were over 18 and still ambulant were included in this 
report.  
 
Statistical analysis 10 
Descriptive statistics were performed where applicable. 
 
Prevalence of falls in the German sample was calculated as a proportion of individuals who have had at 
least one fall within the previous year. Prevalence of fractures in the German sample was calculated as a 
proportion of individuals who have had at least one fracture within the last year. The estimations for the 15 
English and Dutch samples were calculated in the same manner, as the prevalence of at least one fall in 
the last six months and as the prevalence of at least one fracture in the last two years, accordingly.  
 
The prevalence estimates were age-standardised by using weights based on the age distribution of the 
entire sample of patients combined (German, English, and Dutch). Prevalence was reported as 20 
percentages both for crude and age-adjusted estimates. For every estimate a 95% confidence interval (CI) 
was calculated. Each sample was substratified into two strata based on sex and into six age strata: 18-25, 
26-35, 36-45, 46-55, 56-65, and 66-85 years old. The proportions of the six age strata in the overall 
sample were used as weights for the age-standardised estimates. 
 25 
Odds ratios (OR) with 95% CI were calculated for sex and age for the entire sample of 570 patients. For 
this purpose, patients were further categorised into two groups of exposure: younger (18-65) and older 
(66-85).  
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We performed sensitivity analyses by estimating individual OR for different sub-groups: young (18-35), 5 
middle-aged (36-55), and old (56-85), as well as for the above-mentioned six age categories. OR are 
presented for each centre separately and for both sex and age. 
 
Raw data were collected in Microsoft Excel and further analysed using the R statistical computing system, 
version 3.2.2 (17). 10 
 
RESULTS  
 
A total of 1211 questionnaires were sent out (510 via the UK Registry, 132 via the Dutch registry and 569 
via the German Registry). A total of 570 responses were received with a response rate of 47% (49% UK, 15 
76% the Netherlands and 39% Germany). The respondents’ demographic distribution showed 46% of 
males (50% UK, 50% the Netherlands and 45% Germany) and a mean age of 46 (SD 13) (min 18 – 82 max) 
(Figure 1).  
 
Results have been summarized in Table 1. The overall estimates predict a prevalence of falls and fractures 20 
of 30% and 6-11% respectively when asked about the last 6 months and of 70% of falls and 17% of 
fractures when asked about the last 12 months. From all those reporting a fall, one to three falls within 
the periods of 6 and 12 months was the most common answer-option selected. Five percent of the 
respondents complained about falling more than five times within 6-month periods and 12% when asked 
within a year. Among the three countries, the most common reported causes for falling were weakness in 25 
legs (22-44%) and impaired balance (38%) (Figure 2). Among the responses identified as ‘other’, they 
were explained by respondents: 1) by referring to particular daily life situations, such as cycling, walking 
the dog, getting out of the car, walking on uneven surfaces or walking too fast; 2) to lack of concentration, 
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distractions or ‘clumsiness’ (9 times); 3) to other symptoms like fatigue (3 times), low blood pressure 5 
(twice) or dizziness (once); or 4) reported alcohol consumption (twice).  
Figure 1 presents the age distribution of those reporting falls against the total sample size stratified by 
age groups. The age group with the highest number of falls was reported by those 56-65 years old (with a 
prevalence between countries of 42-89%) followed consecutively by the groups 36-45 (30-73%) and 46-55 
(28-71%). The age group with the highest number of fall-associated fractures was consistently the age 10 
group of those who were 56-65 years old (with a prevalence between countries of 13-30%). Distal joints 
were the most frequent site of fractures, with the ankle and foot (toes included) accounting for half of the 
fractures (Table 1). There were no hip fractures reported. Fractures mentioned as ‘others’ included the 
ribs, sternum and maxilla. In total 16 (14%) patients reported fractures in more than one region of the 
body. The English and German questionnaire versions included items on fracture treatment, and 18 (23%) 15 
of the fractures were treated with surgery, 14 of which were from the UK cohort (45%).  
 
When analysing the full sample by sex, men showed a significantly higher incidence of falls in the UK and 
the Netherlands, but women presented the higher incidence of fractures overall. However, when the data 
were standardised to age differences in falls the prevalence between the sexes disappeared in the cohort 20 
from the Netherlands. On the other hand, in fall-associated fractures, sex differences prevail (Table 2).  
 
 
Odds ratio estimates 
Estimated odds ratios for sex and age are given in Table 3. The odds ratio for females over males indicate 25 
the odds of having a fall of 0.94 [95% CI: 0.68, 1.31] and the odds of having a fracture as an outcome were 
1.28 [95% CI: 0.78; 2.10]. Odds ratio estimates comparing an older cohort (65-85 years old) to the 
younger one (younger than 65 years) were 0.44 [95% CI: 0.23; 0.83] and 1.00 [95% CI: 0.41; 2.44], for falls 
and fractures respectively. Sensitivity analyses were consistent with the primary findings regarding sex. 
However, the results showed that when stratifying the sample into three instead of two age groups and 30 
changing the thresholds for the age ranges into: young (18-35); middle-aged (36-55); and old (56-85), the 
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middle-aged group had higher odds of falling compared to the young patients – OR: 1.61 [95% CI: 1.06; 5 
2.44]. Sub-stratifying the sample further into six age categories confirmed the primary findings and those 
of the first age sensitivity analysis. The middle-aged group of 36-45 years old had higher odds of falling 
compared to the younger group of 26-35 years old – OR: 1.78 [95% CI: 1.05; 3.02]. The oldest group of 65-
85 years old had lower odds of falling compared to the group of 56-65 years old – OR: 0.27 [95% CI: 0.13; 
0.57].  10 
 
DISCUSSION 
 
This study identified and quantified the prevalence of falls and fall-associated fractures in myotonic 
dystrophy type 1 via a retrospective multinational survey. The total sample size obtained (N=573) 15 
constitutes a significant achievement in a rare disease such as DM1 and allowed for the identification of 
the prevalence of falls with high confidence (18, 19). The respondents’ demographics provided an even 
distribution by sex and a similar age distribution between the three countries. The mean age of this study 
compares to previous reports on falls in DM and other neuromuscular disorders so allowing for 
meaningful comparisons (6, 19-21). 20 
 
As part of healthy ageing, people of 65 years old and over have been identified as the cohort with the 
highest risk of falls, with at least 1 in every 3 persons >65 years old falling per year (annual incidence of 
30%) (22, 23). However, in the particular case of DM1, older patients seem to have 56% lesser odds for 
falling, and inversely patients younger than 65 have 2.3 times higher (Figure 1 and Table 3). Still, this does 25 
not seem to affect their odds of having a fracture. Due to the natural progression of the disease, this 
might be explained by an assumption that the cohort of DM1 patients between 30 and 60 years old is 
more likely represented by classic or earlier disease-onset respondents, while those over 60 years old (still 
ambulant) may represent in part a milder or late-onset phenotype, who are characterized by a better 
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preserved muscle strength and less disease severity, but this is just an assumption as no other variable for 5 
disease severity has been included for analysis except for the fact that all report to be non-wheelchair 
users.  
 
Approximately 10-20% of falls in the elderly population result in fractures, which is a similar rate as 
presented in this report for DM1 (24). The clinical relevance of lower-limb distal fractures in progressive 10 
muscle disorders is that these fractures may lead to permanent loss of function and wheelchair 
dependency (25). This might not always be the case in DM1 as there is a slower progression of muscle 
weakness, but it is certainly a potential risk to consider when dealing with fractures in more severely 
affected patients. Other types of injuries or consequences due to falling should also be considered and 
investigated as these might impact on patients’ subsequent functional and emotional status. The most 15 
common fracture location associated with osteoporosis is hip fracture, which was not reported in this 
study. However, it would be necessary to correlate vitamin D3 levels and bone density to draw further 
conclusions (26, 27). We should also consider that hip fractures are in general more common in older 
people. This may represent the more severely affected patients who are likely to be non-ambulant and 
were therefore excluded from this study (20). 20 
 
In DM1, men more frequently present severe combined muscular disability with weakness, atrophy and 
myotonia, and cognitive impairment than women (28). These findings present men with a higher 
prevalence of falls compared to women, but women have a higher prevalence of fractures. However, 
odds ratio (OR) estimations showed that sex does not play a role in the odds of having a fall with a 25 
fracture (Tables 2 and 3).  
 
The associated limitations of this study are those naturally associated with a retrospective survey-based 
study. This questionnaire is not a validated falls-reported outcome, neither a falls-specific survey, but a 
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registry-based questionnaire created specifically for this disease group and among a few other events 5 
queried, falls and fall-related fractures prevail. Additionally, as no official definition of “fall” has been 
introduced to the respondent, this provides room for different interpretations. No distinction between 
falls or stumbles was made and it would have been expected to see more stumbles than falls (5). Still, this 
report included the largest number of adult DM1 patients in a study on falls so far and under the authors’ 
understanding, the largest among neuromuscular disorders as well. As a voluntary survey, it may 10 
primarily attract participants with a specific interest in the study results so leading to recruitment bias. 
However, there is a good distribution of age and sex among the respondents, representative of the 
registry populations overall and as a non-exclusive falls survey, it is likely to have included respondents 
more interested in any of the other topics included.  
 15 
CLINICAL IMPLICATIONS 
 
These results provide more detailed information on the prevalence of falls and related fractures in a 
relatively large DM1 population from European countries. This registry-based sample represent a likely 
population to be included in prospective clinical trials which makes our study results relevant as a 20 
benchmark for possible adverse events (falls and associated fractures) which will be encountered when 
conducting a trial in DM1. This should be considered both when reporting adverse events and considering 
an endpoint selection in clinical trials. Furthermore, in the clinical and research setting steps should be 
taken to prevent falls where possible.  
 25 
So far, very few attempts to improve patients’ balance and strength have been made and with no clinical 
significant success (11, 29-31). However, there are other factors associated with falling still to be 
addressed and that multidisciplinary teams involved with these patients should consider preventive 
approaches. Hammaren (6, 31) suggested a minimum annual follow-up for patients with Muscular 
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Impairment Rating Scale (MIRS) scores of 3 or higher and the recommendation of ankle orthotics (AFOs) 5 
where appropriate as minimal standard of care in this population. This team also demonstrated the 
impact of a balance exercise-programme on the balance self-confidence (31). DiPaolo (8) suggested that 
timely introduction of a walking assistive device may be a preventive method for severe falls in DM1. 
Additionally, preventable factors that can increase the risk of falling are: alcohol consumption; risky daily 
life activities; or associated symptoms such as fatigue or low blood pressure, to be identified by treating 10 
clinicians, physiotherapists or occupational therapists, and potentially expert teams for falls and fall 
prevention. 
 
CONCLUSIONS 
 15 
To the best of the authors’ knowledge this report represents the largest sample looking at the prevalence 
of falls in Myotonic Dystrophy type 1 to date. These results suggest that middle-aged ambulant patients 
have the highest risk of falling similar to a healthy population of 20 years older and an increased risk of 
fractures in women. Clinicians and researchers should be aware of these risks and consider fall prevention 
methods when developing care plans for patients with DM1.  20 
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Table 1. Demographics and distribution of responses related to falls and fractures due to falling. NA 
(not applicable) when the question was not part of the country-specific questionnaire. For questions 
of “cause of falling” and “type of fracture”, respondents were allowed to select more than one option. 20 
*Stumbling was only included as an option in the Dutch version of the questionnaire.  
Figure 1. A. B. and C. Age distribution of those reporting falling in the last 12 months for the German 
(A) (German Registry) sample and for the last 6 months for the English (B) (UK Registry) and the 
Dutch (C) (The Netherlands Registry). D. Age distribution within the whole sample. 
Figure 1. Summary of the distribution of causes of falls reported among the whole sample 25 
(prevalence %).   
Table 2. Estimated prevalence of falls (A and B) and fall-associated fractures (C and D) by sex. A. 
presents the distribution of falls between the sexes overall, and table B presents the estimates when 
age-standardized. C. presents the distribution of associated falls between the sexes and table D 
presents the estimates when age-standardized. *Significantly higher (p <0.05). 30 
Table 3. Odds ratio estimations for the entire sample of 570 patients: number of individuals, 
stratified based on sex and age, who have fallen and had an associated fracture. ns (non-significant or 
p≥0.05). 
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Figure 2. A. B. and C. Age distribution of those reporting falling in the last 12 months for the German (A) (German Registry) sample and for 
the last 6 months for the English (B) (UK Registry) and the Dutch (C) (The Netherlands Registry). D. Age distribution within the whole sample. 
 
Figure 3. Summary of the distribution of causes of falls reported among the whole sample (prevalence %).   10 
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Table 1. TOTAL UK 
The 
Netherlands 
Germany 
N (% males) 570 (48%) 250 (49%) 100 (50%) 220 (45%) 
Age - mean (SD) 46.3(±13) 47(±13) 46(±13) 46(±13) 
Subjects reporting falling 
in the last 12 months (%) 
NA NA NA 155 (70%) 
Prevalence of fractures 
among fallers in the last 12 
months (%) 
NA NA NA 16 (10%) 
Subjects reporting falling 
in the last 6 months (%) 
NA 74 (29%) 45 (45%) NA 
Prevalence of fractures 
among fallers in the last 2 
years (%) 
NA 16 (22%) 7 (16%) NA 
Overall prevalence of falls 
(age-standardised) (95% 
CI) 
48% (29-72) 29.6% (29.2-29.9) 30.6% (29.7-31.5) 69.7% (67.7-71.8) 
Overall prevalence of 
fractures (age-
standardised) (95% CI) 
27% (11-17) 10.9% (10.8-11) 6.6% (6.5-6.7) 16.9% (16.7-17) 
Attributed cause of falling 
N (% among responses) 
1. Balance – 260 (39%) 
2. Leg weakness – 244 
(37%) 
3. Stiffness – 100 (15%) 
4. Other – 45 (7%) 
5. Impaired vision – 16 
(2%) 
1. Balance – 131 
(38%) 
2. Leg weakness – 115 
(33%) 
3. Stiffness – 56 (15%) 
4. Other – 35 (10%) 
5. Impaired vision – 
11 (3%) 
1. Balance – 35 (38%) 
2. Leg weakness – 20 
(22%) 
3. Stiffness – 5 (5%) 
4. Other – 3 (3%) 
5. Impaired vision – 3 
(5%) 
*Stumbling – 26 (27%) 
1. Balance – 94 (38%) 
2. Leg weakness – 109 
(44%) 
3. Stiffness – 39 (15%) 
4. Other – 7 (3%) 
5. Impaired vision – 2 
(1%) 
Type of fracture 
N (% among fractures) 
1. Upper limb – 39 (41% 
of all reported 
fractures) 
2. Lower limb – 49 
(52%) 
3. Other – 6 (6%) 
1. Hand – 7 (23%) 
2. Shoulder – 3 (10%) 
3. Elbow and arm - 
2(6%) 
4. Foot – 11 (35%) 
5. Leg – 4 (13%) 
6. Ankle – 3 (10%) 
7. Other – 2 (6%) 
8. Spine – 1 (3%) 
 
1. Hand – 3 (38%) 
2. Ankle and foot – 2 
(25%) 
3. Leg – 1 (13%) 
 
1. Hand – 10 (21%) 
2. Elbow, arm, 
shoulder – 4 (9%) 
3. Leg – 1 (2%) 
4. Foot – 15 (32%) 
5. Ankle – 10 (21%) 
6. Spine – 3 (6%) 
Table 4. Demographics and distribution of responses related to falls and fractures due to falling. NA (not applicable) when the question was 
not part of the country-specific questionnaire. For questions of “cause of falling” and “type of fracture”, respondents were allowed to select 
more than one option. *Stumbling was only included as an option in the Dutch version of the questionnaire.  
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A 
  
  
Non-standardized estimates of falls:  C 
  
  
Non-standardized estimates of fractures: 
Men Women Men Women 
Prevalence 95% CI Prevalence 95% CI Prevalence 95% CI Prevalence 95% CI 
Munich 67% [63; 72] 71% [67; 75] Munich 16% [16; 17] 18% [17.7; 18.4]* 
Newcastle 33% [32; 34] 26% [26; 27]* Newcastle 9.7% [9.5; 9.9] 12.7% [12.5; 12.9]* 
Nijmegen 50% [46, 54] 40% [37; 43]* Nijmegen 6% [5.8; 6.3] 8% [7.7; 8.3]* 
 
B 
  
  
Age-standardized estimates of falls:  D 
  
  
Age-standardized estimates of fractures: 
Men Women Men Women 
Prevalence 95% CI Prevalence 95% CI Prevalence 95% CI Prevalence 95% CI 
Munich 69% [65; 74] 68% [64; 71] Munich 16% [15.7; 16.5] 17% [16.8; 17.5]* 
Newcastle 30% [29; 30.5] 27% [26; 28]* Newcastle 10 % [10; 10.3] 12.9% [12.7; 13.1]* 
Nijmegen 45% [42, 48] 40% [37; 43] Nijmegen 5% [4.7; 5] 8.6% [8.2; 9]* 
Table 5. Estimated prevalence of falls (A and B) and fall-associated fractures (C and D) by sex. A. presents the distribution of falls between 10 
the sexes overall, and table B presents the estimates when age-standardized. C. presents the distribution of associated falls between the 
sexes and table D presents the estimates when age-standardized. *Significantly higher (p <0.05) 
 
Variable Exposure Not-exposed Outcome OR 95% CI Meaning odds are: 
Sex Female Male 
Fall 0.94 [0.68; 1.31] ns 
Fracture 1.28 [0.78; 2.10] ns 
Age 
Old (65-85) Young (18-65) 
Fall 0.44 [0.23; 0.83]* LOWER 
Fracture 1.00 [0.41; 2.44] ns 
Middle (36-55) Young (18-35) 
Fall 1.61 [1.06; 2.44]* HIGHER 
Fracture 1.55 [0.76; 3.17] ns 
Old (56-85) Middle (36-55) 
Fall 1.05 [0.71; 1.55] ns 
Fracture 1.61 [0.94; 2.78] ns 
Table 6. Odds ratio estimations for the entire sample of 570 patients: number of individuals, stratified based on sex and age, who have fallen 
and had an associated fracture. ns (non-significant or p≥0.05) 15 
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